Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Reader Login
 
Search Article 
  
Advanced search 
  Users Online: 730 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2004| April-June  | Volume 6 | Issue 2  
    Online since August 13, 2011

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Adrenal Incidentaloma – Experience Of A Private Referral Centre

April-June 2004, 6(2):47-49
Introduction: Adrenal incidentalomas are a rare but vexing problem for the endocrinologist. There are no Indian data on the subject. The study objective was to look at the characteristics of a group of patients with adrenal incidentaloma from Eastern India. Material And Methods: Retrospective study in a private endocrinology clinic handling refered case in 23 patients seen between 1996 and 2003. Measurements: Clinical and radiological outcome measures. Results: 12 patients were followed up and 11 patients were advised surgery. Of the 8 patients who eventually had surgery, 5 had adrenal adenoma, 2 had adrenal carcinoma and 1 had fat necrosis following pancreatitis. Persistent pain was taken as an indication for surgery. Of the patients advised follow up, 2 were diagnosed adrenal histoplasmosis and one as probable tuberculosis. Conclusions FANC was a good tool in hypodense lesions of probable infective aetiology. Leison size was important in decision making but other imaging information was not. Poorly localized pain was an indication for surgery and gave good results.
[ABSTRACT]   Full text not available  [PDF]
  419 89 -
Treatment Of Osteoporosis - Why, Whom, When And How To Treat

April-June 2004, 6(2):60-62
The rigorously investigated drugs reported to reduce vertebral fractures are alendronate, risedronate, raloxifena and PTH HRT is no longer first choice for fracture prevention given the risk for adverse events, even though these risks are small. Evidence supporting the use of calcitonin, fluoride, anabolic steroids, active vitamin D metabolites is inadequate. The rigorously investigated drugs reported to reduce non-vertebral fractures are the two bisphosphonates and PTH. Evidence for anti-hip fracture efficacy is confined to the two bisphosphonates. Calcium and vitamin D and hip protectors have been reported to reduce hip fractures in institutionalized elderly. Women and men with fragility fractures should be treated with agents that have been thoroughly investigated.
[ABSTRACT]   Full text not available  [PDF]
  402 106 -
History Of Endocrinology

April-June 2004, 6(2):50-52
Full text not available  [PDF]
  277 215 -
SAMTA Polypill (Statins, Aspirin, Metformin And Antihypertensive Agents Such As Thiazides And ACE Inhibitors Or Angiotensin Receptor Blocker) - ‘Aspostatinoprilololazide Folate’ Of Type 2 Asian Indian Diabetic

April-June 2004, 6(2):45-46
Full text not available  [PDF]
  257 190 -
Hypertension In Diabetes

April-June 2004, 6(2):53-59
Full text not available  [PDF]
  223 107 -
Pseudohypoparathyroidism – A Case Report

April-June 2004, 6(2):72-74
Full text not available  [PDF]
  176 121 -
Hypertension : Molecular Approach

April-June 2004, 6(2):63-71
Full text not available  [PDF]
  165 96 -
  Feedback 
  Subscribe